Given the increasing survival rates and evolving patient profiles, future research from our group aims to further investigate risk stratification strategies, familial cancer predisposition, and the potential role of novel imaging techniques such as 68Ga-PSMA PET-CT in improving post-biopsy surveillance. This evidence concerns the gene FOLH1 and cancer.